Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial

PURPOSE: Clinically validated biomarkers for anti-angiogenesis agents are not available. We have previously reported associations between candidate VEGFA SNPs and overall survival (OS) in E2100. The associations between tumor VEGFA amplification and outcome are evaluated here. PATIENTS AND METHODS:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schneider, Bryan P., Gray, Robert J., Radovich, Milan, Shen, Fei, Vance, Gail, Li, Lang, Jiang, Guanglong, Miller, Kathy D., Gralow, Julie R., Dickler, Maura N., Cobleigh, Melody A., Perez, Edith A., Shenkier, Tamara N., Nielsen, Kirsten Vang, Müller, Sven, Thor, Ann, Sledge, George W., Sparano, Joseph A., Davidson, Nancy E., Badve, Sunil S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3594423/
https://ncbi.nlm.nih.gov/pubmed/23340303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-3029
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados